Welcome to the MDCSCO Web Site!
Here you will find information on our upcoming events and on our latest news.
MDCSCO is an affiliate of the American Society of Clinical Oncology. For more information on MDCSCO, go to http://www.mdcsco.org
ASCO Awards $10,000 to Five State Oncology Societies Through State Affiliate Grant Program
The American Society of Clinical Oncology (ASCO) awarded $10,000 grants to five of its State and Regional Affiliates to fund projects that address the varying needs of oncologists and people with cancer in their communities. More information...
ASCO's Guide on Chemoprevention for Prostate Cancer using Finasteride
What's a good way to discuss cancer chemoprevention with interested patients? Decision Aids and Discussion Guides showing and describing risks and benefits can help shared decision-making. Check out ASCO's Guide Here.
ASCO Features MDCSCO Foundation
A recent article in the ASCO News and Forum online newsletter spotlights the MDCSCO's newly formed Oncology Foundation Maryland and the District of Columbia. Click here to view.
Novartis Pharmaceuticals Corporation Announces Afinitor tablets
Novartis Pharmaceuticals Corporation is pleased to announce the introduction of Afinitor® (everolimus) tablets, approved by the FDA on March 30, 2009. Afinitor® is a once daily oral mTOR inhibitor indicated for the treatment of advanced Renal Cell Carcinoma (RCC). Afinitor® is available by prescription only and package in a blister card. Click here for more information.
Our Corporate Members:
Diamond Member: Amgen
Platinum Member: Ortho Biotech
Gold Member: Novartis
(Sponsor of our February event)
|
